Adhera Therapeutics (ATRX) Stock Statistics & Valuation Metrics

Adhera Therapeutics has a market cap or net worth of $722.00. The enterprise value is ―.

Adhera Therapeutics has 7,220,900 shares outstanding. The number of shares has decreased by -2.65% in one year.

Adhera Therapeutics’s return on equity (ROE) is 0.10 and return on invested capital (ROIC) is 11.90%.

The current PE Ratio of Adhera Therapeutics is ―. Adhera Therapeutics’s PEG ratio is 0.00993.

In the last 12 months, Adhera Therapeutics had revenue of 0.00 and earned -2.11M in profits. Earnings per share was -1.18.

In the last 12 months, operating cash flow was -808.15K and capital expenditures 0.00, giving a free cash flow of -808.15K billion.

Adhera Therapeutics pays an annual dividend of ―, resulting in a dividend yield of ―

Adhera Therapeutics upcoming earnings date is ―, ―.

Adhera Therapeutics as a current ratio of <0.01, with Debt / Equity ratio of -38.70%

In the past 12 months, Adhera Therapeutics has paid 0.00 in taxes.

Adhera Therapeutics EV to EBITDA ratio is -6.46, with an EV/FCF ratio of -7.38.

Adhera Therapeutics has $32.39K in cash and marketable securities with $10.83M in debt, giving a net cash position of -$10.80M billion.

Gross margin is 0.00%, with operating margin of 0.00%, and net profit margin of 0.00%.

The average price target for Adhera Therapeutics is ―, which is 11.43% higher than the current price. The consensus rating is ―